Insider Transactions in Q2 2021 at Privia Health Group, Inc. (PRVA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Jaewon Ryu Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,944
+50.0%
|
-
|
|
May 11
2021
|
Brighton Health Group Holdings, LLC |
SELL
Other acquisition or disposition
|
Direct |
79,178,464
-100.0%
|
-
|
|
May 04
2021
|
Goldman Sachs Group Inc > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50
-0.0%
|
$1,700
$34.93 P/Share
|
|
May 04
2021
|
Mbd Advisors, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50
-0.0%
|
$1,700
$34.93 P/Share
|
|
May 03
2021
|
Pamplona Capital Partners Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|
|
May 03
2021
|
Jeffrey Daniel Bernstein Director |
SELL
Open market or private sale
|
Indirect |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|
|
May 03
2021
|
Brighton Health Group Holdings, LLC |
SELL
Open market or private sale
|
Direct |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|
|
May 03
2021
|
Goldman Sachs Group Inc > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|
|
May 03
2021
|
Mbd Advisors, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,700,000
-17.42%
|
$350,700,000
$21.62 P/Share
|
|
May 03
2021
|
Thomas A Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,695
+34.78%
|
$199,985
$23.0 P/Share
|
|
Apr 30
2021
|
Goldman Sachs Group Inc > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000
-0.0%
|
$340,000
$34.5 P/Share
|
|
Apr 30
2021
|
Goldman Sachs Group Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.0%
|
$340,000
$34.5 P/Share
|
|
Apr 30
2021
|
Mbd Advisors, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000
-0.0%
|
$340,000
$34.5 P/Share
|
|
Apr 30
2021
|
Mbd Advisors, L.L.C. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.0%
|
$340,000
$34.5 P/Share
|
|
Apr 29
2021
|
Goldman Sachs Group Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50
+0.0%
|
$1,450
$29.24 P/Share
|
|
Apr 29
2021
|
Mbd Advisors, L.L.C. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50
+0.0%
|
$1,450
$29.24 P/Share
|
|
Apr 28
2021
|
William M Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,609
+50.0%
|
-
|
|
Apr 28
2021
|
Jeffrey B Butler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,609
+50.0%
|
-
|
|
Apr 28
2021
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,609
+50.0%
|
-
|
|
Apr 28
2021
|
Thomas A Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,609
+50.0%
|
-
|
|
Apr 28
2021
|
Parth Mehrotra Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
97,391
+50.0%
|
-
|
|
Apr 28
2021
|
David P King Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,609
+50.0%
|
-
|
|
Apr 28
2021
|
Matthew Shawn Morris Director |
BUY
Grant, award, or other acquisition
|
Direct |
121,739
+50.0%
|
-
|
|
Apr 28
2021
|
Thomas Bartrum |
BUY
Grant, award, or other acquisition
|
Direct |
27,391
+50.0%
|
-
|
|
Apr 28
2021
|
David Mountcastle EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,826
+23.12%
|
-
|